TY - JOUR
T1 - Blood pressure variability
T2 - methodological aspects, clinical relevance and practical indications for management - a European Society of Hypertension position paper
AU - Parati, Gianfranco
AU - Bilo, Grzegorz
AU - Kollias, Anastasios
AU - Pengo, Martino
AU - Ochoa, Juan Eugenio
AU - Castiglioni, Paolo
AU - Stergiou, George S.
AU - Mancia, Giuseppe
AU - Asayama, Kei
AU - Asmar, Roland
AU - Avolio, Alberto
AU - Caiani, Enrico G.
AU - De La Sierra, Alejandro
AU - Dolan, Eamon
AU - Grillo, Andrea
AU - Guzik, Przemysław
AU - Hoshide, Satoshi
AU - Head, Geoffrey A.
AU - Imai, Yutaka
AU - Juhanoja, Eeva
AU - Kahan, Thomas
AU - Kario, Kazuomi
AU - Kotsis, Vasilios
AU - Kreutz, Reinhold
AU - Kyriakoulis, Konstantinos G.
AU - Li, Yan
AU - Manios, Efstathios
AU - Mihailidou, Anastasia S.
AU - Modesti, Pietro Amedeo
AU - Omboni, Stefano
AU - Palatini, Paolo
AU - Persu, Alexandre
AU - Protogerou, Athanasios D.
AU - Saladini, Francesca
AU - Salvi, Paolo
AU - Sarafidis, Pantelis
AU - Torlasco, Camilla
AU - Veglio, Franco
AU - Vlachopoulos, Charalambos
AU - Zhang, Yuqing
PY - 2023/4/1
Y1 - 2023/4/1
N2 - Blood pressure is not a static parameter, but rather undergoes continuous fluctuations over time, as a result of the interaction between environmental and behavioural factors on one side and intrinsic cardiovascular regulatory mechanisms on the other side. Increased blood pressure variability (BPV) may indicate an impaired cardiovascular regulation and may represent a cardiovascular risk factor itself, having been associated with increased all-cause and cardiovascular mortality, stroke, coronary artery disease, heart failure, end-stage renal disease, and dementia incidence. Nonetheless, BPV was considered only a research issue in previous hypertension management guidelines, because the available evidence on its clinical relevance presents several gaps and is based on heterogeneous studies with limited standardization of methods for BPV assessment.The aim of this position paper, with contributions from members of the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability and from a number of international experts, is to summarize the available evidence in the field of BPV assessment methodology and clinical applications and to provide practical indications on how to measure and interpret BPV in research and clinical settings based on currently available data. Pending issues and clinical and methodological recommendations supported by available evidence are also reported. The information provided by this paper should contribute to a better standardization of future studies on BPV, but should also provide clinicians with some indications on how BPV can be managed based on currently available data.
AB - Blood pressure is not a static parameter, but rather undergoes continuous fluctuations over time, as a result of the interaction between environmental and behavioural factors on one side and intrinsic cardiovascular regulatory mechanisms on the other side. Increased blood pressure variability (BPV) may indicate an impaired cardiovascular regulation and may represent a cardiovascular risk factor itself, having been associated with increased all-cause and cardiovascular mortality, stroke, coronary artery disease, heart failure, end-stage renal disease, and dementia incidence. Nonetheless, BPV was considered only a research issue in previous hypertension management guidelines, because the available evidence on its clinical relevance presents several gaps and is based on heterogeneous studies with limited standardization of methods for BPV assessment.The aim of this position paper, with contributions from members of the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability and from a number of international experts, is to summarize the available evidence in the field of BPV assessment methodology and clinical applications and to provide practical indications on how to measure and interpret BPV in research and clinical settings based on currently available data. Pending issues and clinical and methodological recommendations supported by available evidence are also reported. The information provided by this paper should contribute to a better standardization of future studies on BPV, but should also provide clinicians with some indications on how BPV can be managed based on currently available data.
KW - blood pressure variability
KW - blood pressure variability assessment methodology
KW - blood pressure variability management
KW - cardiovascular prevention
KW - cardiovascular risk factors
KW - hypertension management
UR - https://www.scopus.com/pages/publications/85149665680
U2 - 10.1097/HJH.0000000000003363
DO - 10.1097/HJH.0000000000003363
M3 - Article
C2 - 36723481
AN - SCOPUS:85149665680
SN - 0263-6352
VL - 41
SP - 527
EP - 544
JO - Journal of Hypertension
JF - Journal of Hypertension
IS - 4
ER -